Haematology Centre

Leukaemia

Leukaemia is a type of blood cancer that typically begins in the bone marrow, resulting in high numbers of abnormal blood cells.

Recognising the signs of leukaemia early is crucial for treatment, which can improve survival rate.

Lymphoma

Lymphoma is a blood cancer affecting cells of the immune system.

It is broadly classified into Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, with treatments offering targeted therapy options.

Recognising the signs of leukaemia early is crucial for treatment, which can improve survival rate.

Multiple Myeloma

Multiple myeloma is a bone marrow cancer that affects plasma cells, a critical part of the immune system.

The condition can weaken bones and lead to complications such as anaemia.

A diagnosis is essential for developing an effective treatment plan.

Myelodysplastic Syndrome

Myelodysplasia, or MDS, is a rare type of blood cancer where the bone marrow does not produce enough healthy blood cells.

Early detection can lead to effective MDS treatments, which may include medications, transfusions, or bone marrow transplants.

Myeloproliferative Neoplasms

Myeloproliferative Neoplasms, or MPNs, are another group of rare blood cancers, characterised by the excessive production of blood cells in the bone marrow.

They require careful monitoring and treatment to manage symptoms and prevent complications.